The Mobetron is a mobile electron accelerator designed to deliver therapeutic radiation dose intraoperatively while diseased tissue is exposed. Experience with the Mobetron 1000 has been reported extensively. However, since the time of those publications a new model, the Mobetron 2000, has become commercially available. 
| INTRODUCTION
Intraoperative radiation therapy (IORT) aims to maximize the therapeutic ratio, which represents the balance between tumor control and normal tissue toxicity. At the time of tumor resection, it may be possible to provide a direct path between an accelerator and the tumor bed since the overlying tissues are moved out of the way. When the resection leaves behind a thin region of unresected tumor cells (either microscopic or macroscopic), the use of intraoperative high-dose-rate brachytherapy (IORT-HDR), low energy photons, or megavoltage electrons can provide a therapeutic dose to the tumor bed while minimizing damage to distal tissues. Accordingly, IORT has found several clinical applications using a number of different delivery devices for sites such as sarcomas, [1] [2] [3] breast, 4,5 recurrent head and neck cancer, 6 pancreatic cancer, 7 locally advanced and recurrent GYN tumors, 8 rectal cancers, 9,10 and genitourinary cancers.
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Delivery of IORT is most easily performed in the operating theater (OR) within a sterile environment to avoid transferring the patient from the operating theater to a linear accelerator in a radiation oncology department. Several accelerators capable of being placed in an operating room have been marketed:
• Mobetron, IntraOp Medical Corporation, Sunnyvale, CA (6, 9, 12 MeV electrons); and
• NOVAC, Sordina IORT Technologies, Vicenza, Italy (4, 6, 8, 10 MeV electrons). 13 To some extent, the commissioning of such a system is very similar to the commissioning of a normal therapeutic megavoltage electron linear accelerator or superficial unit. However, there are a number of important differences as well. 14 These differences include the lack of isocentricity and the use of dedicated applicators that are markedly different than conventional electron applicators.
This report details the implementation of an IORT program at our institution using the Mobetron, manufactured by Intraop Medical
Corporation. This device presents a number of challenges for the medical physicist. These include the fact that many are used in unshielded rooms. The design of applicators for oblique treatments makes commissioning and dose planning challenging, particularly
given the lack of a computer-aided planning system. We describe our approaches to these issues over the past 3 years.
Experience commissioning a previous model of the Mobetron, the Mobetron 1000, has been reported previously. 15 However, in the time since that publication a new model has become commercially available, the Mobetron 2000. In light of this, we focus on (a) characteristics that have changed in the new model (such as output factors), (b) supplemental measurements not included in previous publications, and (c) historical use data and experience at our institution. We devote minimal attention to items extensively covered elsewhere such as radiation protection shielding and TG-51 measurements. Overall, our goal is to provide the community with a broad set of beam parameters for comparison and to perhaps provide some guidance to help others develop their own programs using this modality.
| ME TH ODS
We begin by describing the Mobetron and its accessories, focusing on changes in the most current model. We then present our experience, dividing it into three categories: radiation protection, commissioning and dosimetry, and clinical procedures.
2.A | Mobetron description
The Mobetron is a dedicated mobile electron linear accelerator designed to deliver radiation during surgery. It uses X-band frequencies for electron acceleration in order to achieve smaller dimensions and a reduced weight more amenable to use in an operating suite.
The Mobetron 2000 is an improvement in this regard, with a total weight of approximately 3000 lbs. compared to roughly 4000 lbs.
for the prior model. It is also a few inches shorter to accommodate lower ceiling heights. The Mobetron 2000 produces electrons with nominal energies of 6, 9, and 12 MeV at dose rates up to approximately 10 Gy per minute. The 4 MeV setting available in the previous model was eliminated to reduce QA load, instead bolus is used to achieve a similar effect. It is designed without a bending magnet to reduce leakage radiation so that it can be used in operating rooms with minimal shielding (e.g., designed for diagnostic imag- The Mobetron uses a soft docking system in which the accelerator is physically decoupled from the applicator which touches the patient (Fig. 1 ). The Mobetron 2000 includes an improved docking algorithm intended to reduce the time required to achieve docking.
A clamp is secured to the operating table and several pivoting arms hold a collar directly above the treatment site. The collar serves two purposes. The first is to securely hold the applicator itself -one end of which is fixed to the collar while the other rests on the tissue to be treated. Secondly, the other side of the collar (facing the linac) holds an annular mirror. A laser-detector scheme in the linac head is used to provide feedback regarding the absolute alignment (translation and rotation) of the linac and applicator. There is approximately a 4 cm gap between the collar and the end of the linac head. 
2.B | Radiation protection
Several publications 16, 17 have documented the three-dimensional dose distributions resulting from leakage, scatter, and transmission through the beamstopper. Krechetov et al. 18 report such measurements for the current model of the Mobetron. Since a thorough mapping of the dose in the OR and environs requires extensive beam-on time which was not possible in our situation given possible exposure to operators, ancillary personnel, and patients/visitors, we performed a selective set of measurements and compared these with expected values from the aforementioned publications. The feasibility of using the Mobetron in a given OR and the limits on the number of allowable monitor units were based on these publications and our measurements. 
2.C | Dosimetric measurements

2.C.1 | Output factors and air gap measurements
Output factors were measured for each applicator diameter, bevel, and energy combination. The rationale for the geometry of the measurements was described in the AAPM Task Group 48 report. 19 The 
2.C.2 | Percent depth dose and lateral profiles
PDDs were acquired for every applicator, bevel and energy combination, normal to the water surface (i.e., not along the applicator axis for beveled applicators), and centered under the beveled end of the applicator. In-plane and cross-plane profiles were also acquired at a variety of depths for each combination of parameters. with and in contact with the solid water. Profiles were taken for each bevel angle and energy combination using 4, 7, and 10 cm diameter cones. All films were scanned on an Epson V750 flatbed scanner (Seiko Epson Corp., Tokyo, Japan) and converted to relative dose using a triple-channel dosimetry algorithm. [20] [21] [22] To validate film measurements, PDDs from film were compared to PDDs measured with the electron diode and with a parallel plate chamber. In-plane profiles were also compared between film and the electron diode measurements.
2.D | IORT procedures
Integrating the IORT program into the surgical procedures was F I G . 3. Applicator alignment example. The lookup tables assume that the front of the (beveled) applicator is just beyond the border of the target. This takes advantage of the characteristic shape of the 90% isodose coverage: the 'leading edge' of the coverage (i.e., the left hand side of the red line in the figure) exhibits a consistent lateral position with depth, whereas the 'trailing edge' varies considerably in its lateral position. The former conforms well to the hypothetical target, whereas the latter does not. Absolute calibration using the TG-51 protocol was performed in the same manner as with isocentric linacs using a calibrated ion chamber and electrometer. Accuracy of the calibration was confirmed by means of the Radiological Physics Center (currently IROC-Houston) service.
3.B.2 | Output factors and airgap measurements
The were approximately 4 and 3 mm shallower, respectively, than for the other larger cones. 
3.B.4 | 2D Dose distributions
Profiles from film measurements were spot-checked against diode scans and ion chamber measurements (for PDDs) for validation purposes. Film was found to accurately reproduce these profiles, though artifacts were observed at shallow depths for some film profiles.
Comparison of film, diode, and ion chamber profiles are displayed in Lookup tables of applicator diameter energy combinations for 90% isodose coverage are presented in Tables 2-4 . For superficial targets, a cone diameter slightly larger than the target (e.g., 0.5-1 cm) was sufficient. For targets with significant depth extent, the required cone size increased in order to offset isodose constriction.
This was exacerbated for targets requiring beveled applicators, as the applicator size must account for both isodose constriction and the fact that the cone axis is not normal to the surface.
3.C | IORT procedures
The results from 76 daily QA measurements (either pretreatment or as part of monthly QA) spanning 3 years are plotted in Fig. 13 reducing the likelihood that the observed apparent decline in output was permanent or significant. Table 5 and Fig. 14 provide a detailed breakdown of the treatment parameters used for 44 patients treated at our institution.
The majority of patients treated were sarcomas in the abdomen and pelvic regions. We have also treated several head and neck tumors.
One of the biggest issues during procedures was the type of operating (Fig. 15) . This support is being used routinely and has simplified and sped up the docking procedure markedly.
An important issue is the assignment of responsibilities for setting up the applicator and bolus sterilization and storage systems.
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One of the advantages of the latest generation of intraoperative radiation sources is the ability to place them in existing operating suites. However, unless the OR is unusually isolated, there will be limitations on the number of monitor units that can be delivered.
An unusual feature of the Mobetron is the output factors, which increase with decreasing field size. The Mobetron is designed to achieve a flat profile with only one scattering foil for all energies and a fixed collimator, unlike conventional accelerators which have different foils and collimation settings for each energy.
The Mobetron achieves a flat field through the design of the applicators. The applicators have no gaps, and electrons that would normally scatter out of the field will backscatter into the field, resulting in a flatter field. As the applicator size decreases, more electrons are backscattered to a smaller area, increasing the flux and accordingly the output factor. At some point, the applicator becomes small enough that the contribution to dose by backscattered electrons is offset by electrons lost due to the narrow bore (i.e., the entrance aperture), and the output factor begins to decrease. The difference in the output factors between the Mobetron 1000 and 2000 stems from differences in the applicator bores. The Mobetron 1000 bores were smaller to achieve a more consistent output factor. This made treatment field visualization more difficult, however, and increase lateral scatter from the machine as more electrons were intercepted by the bore. The
Mobetron 2000 uses a wide bore design to rectify these issues, which results in relatively higher output factors. It is intended to serve as a second check that parameters selected are reasonable. Examination of the different tables also serves as an illustrative example of the effects of isodose constriction and the effect of bevel angle. The former is illustrated by the increase in the applicator diameter as a function of depth in the 0°bevel table. The latter can be seen by comparing the maximum treatable depth between all three tables, or by comparing the required applicator diameter at a given depth between the tables. As an example of how the table might be used, consider a situation wherein the radiation oncologist would like to treat a 5 cm diameter area to a depth of 1.5 cm with 0.5 cm of bolus to ensure surface dose. Furthermore, suppose that given the geometry of the resection site either a 0°or 15°bevel may be appropriate. Using Table 2 for 0°bevel cones, one would look up the entry for a 5 cm diameter and 2 cm depth (the tables do not include bolus, so the bolus must be added to the depth to be treated), which is 9 MeV/6 cm cone. For the 15°bevel cone, Table 3 indicates that a 9 MeV/6.5 cm cone would be appropriate. One of these two can then be selected based on the geometry of the resection site in light of the required cone size.
The tables have clear limitations. First, they are based mostly on interpolated data between three sets of applicator sizes. However, In the case bolus is used, the correct table target depth to use is the sum of the bolus thickness and depth of tissue to be treated.
We have not encountered a situation wherein the available applicators were not large enough to encompass the tumor bed. However, there are publications detailing field matching for exceptionally large treatment areas, 25 calculations. This may reflect the wide diversity of tumor types and sites that we treat which reduces our ability to develop a more routine, streamlined process.
| CONCLUSION
Intraoperative radiation therapy with the Mobetron has become a standard procedure that the Department of Radiation Oncology provides to the hospital surgical services. Commissioning is a fairly lengthy procedure given the large number of applicators and lack of dedicated access to a properly shielded room. Integration of radiation oncology staff members and the Mobetron into the operating room setting is a challenge with a steep learning curve, but a cooperative, proactive approach can greatly ameliorate these issues.
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